Evidence map›Paper›PMID 31942532›Full record

ArticleAging medicine (Milton (N.S.W))2019

Glutamate ionotropic receptor NMDA type subunit 2A (

Gaurav Nepal, Jessica Holly Rehrig, Rajeev Ojha

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging medicine (Milton (N.S.W)), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. "Janus-Faced" α-Synuclein: Role in Parkinson's Disease.Frontiers in cell and developmental biology · 2021
    Review
  5. Glutamate ionotropic receptor NMDA type subunit 2A (Aging medicine (Milton (N.S.W)) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Gaurav NepalTribhuvan University Institute of Medicine Kathmandu Nepal.ORCID https://orcid.org/0000-0001-5054-2711
Jessica Holly RehrigUniversity of New England College of Osteopathic Medicine Biddeford Maine USA.
Rajeev OjhaDepartment of Neurology Tribhuvan University Institute of Medicine Kathmandu Nepal.
Tribhuvan University · NPNew England College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDopaminergic neuronal degeneration seen in Parkinson's disease (PD) might result from a single nucleotide polymorphism (SNP) in the glutamate ionotropic receptor NMDA type subunit 2A (

methodsWe searched PubMed, EMBASE, Web of Science, Google Scholar, and China National Knowledge Infrastructure for studies published between January 2005 and January 2019. The association between the rs4998386 polymorphism and PD susceptibility was evaluated by calculating the pooled odds ratios (ORs) and 95% confidence intervals (CIs).

resultsMeta-analysis results did not show a significant association between the rs4998386 polymorphism of the

conclusionOur meta-analysis found that the rs4998386 polymorphism of the

Indexed as

Excitotoxicityglutamate ionotropic receptor NMDA type subunit 2ANeurodegenerationNMDA receptorParkinson's diseasers4998386 polymorphism

Identifiers

PMID31942532
PMCPMC6880709
OpenAlexW2963966742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.